Opus Genetics, Inc. Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross
Opus Genetics, Inc. (IRD) reported Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross of 5.93 million shares for the 12-month period ending 2016-12-31, per its 10-K filed 2017-02-24.
Discontinued › Shareholders' Equity › Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Net of Forfeitures
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross · last filed 2017-02-24
- Opus Genetics, Inc. share-based compensation arrangement by share-based payment award, options, grants in period, gross for the quarter ending 2016-12-31 was 50.00K shares.
- Opus Genetics, Inc. share-based compensation arrangement by share-based payment award, options, grants in period, gross for the quarter ending 2016-09-30 was 1.39M shares, a 192.48% increase year-over-year.
- Opus Genetics, Inc. share-based compensation arrangement by share-based payment award, options, grants in period, gross for the quarter ending 2016-06-30 was 1.15M shares, a 283.33% increase year-over-year.
- Opus Genetics, Inc. share-based compensation arrangement by share-based payment award, options, grants in period, gross for the quarter ending 2016-03-31 was 3.34M shares, a 2.60% decline year-over-year.
- Opus Genetics, Inc. share-based compensation arrangement by share-based payment award, options, grants in period, gross for fiscal 2016 was 5.93M shares, a 41.06% increase from fiscal 2015.
- Opus Genetics, Inc. share-based compensation arrangement by share-based payment award, options, grants in period, gross for fiscal 2015 was 4.20M shares, a 66.16% increase from fiscal 2014.
- Opus Genetics, Inc. share-based compensation arrangement by share-based payment award, options, grants in period, gross for fiscal 2014 was 2.53M shares, a 3.20% increase from fiscal 2013.
- Opus Genetics, Inc. share-based compensation arrangement by share-based payment award, options, grants in period, gross for fiscal 2013 was 2.45M shares, a 900.00% increase from fiscal 2012.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 2 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 3 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 6 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 9 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 12 month |
|---|---|---|---|---|---|
| 2016-12-31 | 50.00K shares derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-24 | 1.44M shares derived: sum of 2 quarters · filed 2017-02-24 | 2.59M shares derived: sum of 3 quarters · filed 2017-02-24 | 5.93M shares 10-K · filed 2017-02-24 | |
| 2016-09-30 | 1.39M shares derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-04 | 2.54M shares derived: sum of 2 quarters · filed 2016-11-04 | 5.88M shares 10-Q · filed 2016-11-04 | 5.88M shares derived: sum of 4 quarters · filed 2016-11-04 | |
| 2016-06-30 | 1.15M shares derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-05 | 4.49M shares 10-Q · filed 2016-08-05 | 4.49M shares derived: sum of 3 quarters · filed 2016-08-05 | 4.96M shares derived: sum of 4 quarters · filed 2016-08-05 | |
| 2016-03-31 | 3.34M shares 10-Q · filed 2016-05-06 | 3.34M shares derived: sum of 2 quarters · filed 2016-05-06 | 3.81M shares derived: sum of 3 quarters · filed 2016-05-06 | 4.11M shares derived: sum of 4 quarters · filed 2016-05-06 | |
| 2015-12-31 | 0.00 shares derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-14 | 475.00K shares derived: sum of 2 quarters · filed 2016-03-14 | 775.00K shares derived: sum of 3 quarters · filed 2016-03-14 | 4.20M shares 10-K · filed 2016-03-14 | |
| 2015-09-30 | 475.00K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-02 | 775.00K shares derived: sum of 2 quarters · filed 2015-11-02 | 4.20M shares 10-Q · filed 2015-11-02 | 4.33M shares derived: sum of 4 quarters · filed 2015-11-02 | |
| 2015-06-30 | 300.00K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-07 | 3.73M shares 10-Q · filed 2015-08-07 | 3.86M shares derived: sum of 3 quarters · filed 2015-08-07 | 4.86M shares derived: sum of 4 quarters · filed 2015-11-02 | |
| 2015-03-31 | 3.43M shares 10-Q · filed 2015-05-08 | 3.56M shares derived: sum of 2 quarters · filed 2015-05-08 | 4.56M shares derived: sum of 3 quarters · filed 2015-11-02 | 4.98M shares derived: sum of 4 quarters · filed 2015-11-02 | |
| 2015-03-16 | 3.38M shares 10-K · filed 2015-03-16 | ||||
| 2014-12-31 | 130.00K shares derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-16 | 1.13M shares derived: sum of 2 quarters · filed 2015-11-02 | 1.55M shares derived: sum of 3 quarters · filed 2015-11-02 | 2.53M shares 10-K · filed 2015-03-16 | |
| 2014-09-30 | 1.00M shares derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-02 | 1.42M shares derived: sum of 2 quarters · filed 2015-11-02 | 2.40M shares 10-Q · filed 2015-11-02 | 2.42M shares derived: sum of 4 quarters · filed 2015-11-02 | |
| 2014-06-30 | 422.50K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-07 | 1.40M shares 10-Q · filed 2015-08-07 | 1.42M shares derived: sum of 3 quarters · filed 2015-08-07 | 1.55M shares derived: sum of 4 quarters · filed 2015-08-07 | |
| 2014-03-31 | 976.00K shares 10-Q · filed 2015-05-08 | 1.00M shares derived: sum of 2 quarters · filed 2015-05-08 | 1.13M shares derived: sum of 3 quarters · filed 2015-05-08 | 1.68M shares derived: sum of 4 quarters · filed 2015-05-08 | |
| 2013-12-31 | 25.00K shares derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-16 | 150.00K shares derived: sum of 2 quarters · filed 2015-03-16 | 700.00K shares derived: sum of 3 quarters · filed 2015-03-16 | 2.45M shares 10-K · filed 2015-03-16 | |
| 2013-09-30 | 125.00K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-12 | 675.00K shares derived: sum of 2 quarters · filed 2014-11-12 | 2.42M shares 10-Q · filed 2014-11-12 | 2.42M shares derived: sum of 4 quarters · filed 2014-11-12 | |
| 2013-06-30 | 550.00K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-13 | 2.30M shares 10-Q · filed 2014-08-13 | 2.30M shares derived: sum of 3 quarters · filed 2014-08-13 | 2.30M shares derived: sum of 4 quarters · filed 2014-08-13 | |
| 2013-03-31 | 1.75M shares 10-Q · filed 2014-05-14 | 1.75M shares derived: sum of 2 quarters · filed 2014-05-14 | 1.75M shares derived: sum of 3 quarters · filed 2014-05-14 | 1.92M shares derived: sum of 4 quarters · filed 2014-05-14 | |
| 2012-12-31 | 0.00 shares derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-21 | 0.00 shares derived: sum of 2 quarters · filed 2014-03-21 | 170.00K shares derived: sum of 3 quarters · filed 2014-03-21 | 245.00K shares 10-K · filed 2014-03-21 | |
| 2012-09-30 | 0.00 shares derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-13 | 170.00K shares derived: sum of 2 quarters · filed 2013-11-13 | 245.00K shares 10-Q · filed 2013-11-13 | 295.00K shares derived: sum of 4 quarters · filed 2013-11-13 | |
| 2012-06-30 | 170.00K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-12 | 245.00K shares 10-Q · filed 2013-08-12 | 295.00K shares derived: sum of 3 quarters · filed 2013-08-12 | 445.00K shares derived: sum of 4 quarters · filed 2013-08-12 | |
| 2012-03-31 | 75.00K shares 10-Q · filed 2013-05-09 | 125.00K shares derived: sum of 2 quarters · filed 2013-05-09 | 275.00K shares derived: sum of 3 quarters · filed 2013-05-09 | ||
| 2011-12-31 | 50.00K shares derived: 10-K 12 month − 10-Q 9 month · filed 2013-03-22 | 200.00K shares derived: sum of 2 quarters · filed 2013-03-22 | 450.00K shares 10-K · filed 2013-03-22 | ||
| 2011-09-30 | 150.00K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2012-11-08 | 400.00K shares 10-Q · filed 2012-11-08 | |||
| 2011-06-30 | 250.00K shares 10-Q · filed 2012-08-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| RELMADA THERAPEUTICS, INC. (RLMD) | United States | $0.406B | -11.92 |
| Arcturus Therapeutics Holdings Inc. (ARCT) | $0.402B | -2.05 | |
| GALECTIN THERAPEUTICS INC (GALT) | United States | $0.399B | -11.06 |
| ARS Pharmaceuticals, Inc. (SPRY) | United States | $0.414B | -3.70 |
| Atea Pharmaceuticals, Inc. (AVIR) | United States | $0.414B | -2.26 |
| Turn Therapeutics Inc. (TTRX) | United States | $0.397B | -25.68 |
| DiaMedica Therapeutics Inc. (DMAC) | United States | $0.423B | -10.11 |
| PROTHENA CORP PUBLIC LTD CO (PRTA) | Ireland | $0.428B | -11.53 |
| Rezolute, Inc. (RZLT) | United States | $0.382B | -6.45 |
| CYPHERPUNK TECHNOLOGIES INC. (CYPH) | United States | $0.438B | -75.63 |